Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 4, 2026, 10:44 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 649–672 of 1,551 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Ulcerative Clear all

Conditions: Ulcer Venous, Wound Heal
Interventions: InnovaMatrix® AC Sterilized, Porcine Placental Extracellular Matrix (ECM); Device
Lead sponsor: ConvaTec Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 37 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Cambridge, Massachusetts

Conditions: Diabetic Foot Ulcer, Diabetic Foot, Diabetes
Interventions: Not listed
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years and older
Enrollment: 5,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2028
U.S. locations: 9
States / cities: Tucson, Arizona • Los Angeles, California • San Francisco, California + 6 more

Conditions: Inflammatory Bowel Diseases, Pain, Opioid Use, Crohn Disease, Ulcerative Colitis
Interventions: Proactive Analgesic Inpatient Narcotic-Sparing; Behavioral
Lead sponsor: Cedars-Sinai Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 33 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Venous Leg Ulcer, Venous Stasis Ulcers
Interventions: HP802-247, Placebo (Vehicle); Biological
Lead sponsor: Healthpoint; Industry
Eligibility: 18 Years and older
Enrollment: 228 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2011
U.S. locations: 29
States / cities: Tucson, Arizona • Castro Valley, California • Encinitas, California + 26 more

Conditions: Foot Ulcer, Foot Ulcer, Diabetic
Interventions: Ulcer Measurement Software; Device
Lead sponsor: Linnea Polgreen; Other
Eligibility: 21 Years to 100 Years
Enrollment: 500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2026
U.S. locations: 1
States / cities: Iowa City, Iowa

Conditions: Pressure Ulcers
Interventions: Nutritional Supplement/Amino acids and HMB, Juven; Dietary Supplement
Lead sponsor: Central Arkansas Veterans Healthcare System; Federal
Eligibility: 21 Years to 90 Years
Enrollment: 9 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2010
U.S. locations: 1
States / cities: Little Rock, Arkansas

Conditions: Diabetes, Neuropathic Limb, Elevated Temperature, Shear Pressure, Increased Temperatures
Interventions: TempTouchRM, Offloading; Device
Lead sponsor: Diabetica Solutions Inc.; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 110 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2008
U.S. locations: 1
States / cities: San Antonio, Texas

Conditions: Determine Effectiveness of Theraskin in the Treatment of DFU and VLU
Interventions: Human Allograft (Theraskin); Other
Lead sponsor: Solsys Medical LLC; Industry
Eligibility: 18 Years and older
Enrollment: 188 participants
Timeline: 2003 – 2009
U.S. locations: 1
States / cities: Fairfax, Virginia

Conditions: Diabetic Foot, Ulcer Foot, Wound Heal
Interventions: Wound debridement, Wound closure matrix application; Procedure · Device
Lead sponsor: Polymedics Innovations Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Circleville, Ohio

Conditions: Colitis, Ulcerative
Interventions: Vedolizumab; Drug
Lead sponsor: Takeda; Industry
Eligibility: 2 Years to 17 Years
Enrollment: 121 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2025
U.S. locations: 11
States / cities: Phoenix, Arizona • San Diego, California • Atlanta, Georgia + 8 more

Conditions: Ulcerative Colitis
Interventions: Placebo, HE3286; Drug
Lead sponsor: Harbor Therapeutics; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 27 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2009
U.S. locations: 10
States / cities: Tucson, Arizona • Anaheim, California • Fresno, California + 6 more

Conditions: Ulcerative Colitis, Colitis, Ulcerative
Interventions: VE202, Vancomycin Oral Capsule, VE202 Placebo, Vancomycin Placebo; Biological · Drug · Other
Lead sponsor: Vedanta Biosciences, Inc.; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 114 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 10
States / cities: Naples, Florida • Orlando, Florida • Decatur, Georgia + 6 more

Conditions: Inflammatory Bowel Diseases, Crohns Disease, Ulcerative Colitis, Colitis
Interventions: Not listed
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 18 Years and older
Enrollment: 380 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Ulcerative Colitis and Crohn's Disease
Interventions: Vedolizumab, Other Biologic Agents; Drug · Other
Lead sponsor: Takeda; Industry
Eligibility: 18 Years and older
Enrollment: 5,302 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2021
U.S. locations: 66
States / cities: Birmingham, Alabama • Mobile, Alabama • Tucson, Arizona + 54 more

Conditions: Ulcerative Colitis
Interventions: Apremilast, Placebo; Drug
Lead sponsor: Amgen; Industry
Eligibility: 18 Years and older
Enrollment: 170 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2019
U.S. locations: 25
States / cities: Dothan, Alabama • Los Angeles, California • Bristol, Connecticut + 21 more

Conditions: Venous Ulcers
Interventions: Hyalomatrix extra-cellular matrix, Mepilex wound dressing; Device
Lead sponsor: Calvary Hospital, Bronx, NY; Other
Eligibility: 21 Years to 90 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Newark, New Jersey

Conditions: Delirium, Age-Related Cognitive Decline, Frail Elderly, Hospital Acquired Pressure Ulcer, Drug-Related Side Effects and Adverse Reactions
Interventions: Acute Care of Elders focused geriatric care; Other
Lead sponsor: Oregon Health and Science University; Other
Eligibility: Not listed
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2020
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Inflammatory Bowel Diseases, Ulcerative Colitis, Crohn Disease, C. Diff. Infections
Interventions: Bezlotoxumab; Biological
Lead sponsor: David Binion, MD; Other
Eligibility: 18 Years and older
Enrollment: 19 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Non-infected Venous Leg Ulcer, Venous Leg Ulcer, Venous Insufficiency, Venous Stasis, Venous Reflux
Interventions: BR-AC, Standard Care; Other
Lead sponsor: BioStem Technologies; Industry
Eligibility: 18 Years and older
Enrollment: 71 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 22
States / cities: Guntersville, Alabama • Castro Valley, California • Glendale, California + 16 more

Conditions: Ulcerative Colitis, Active Moderate
Interventions: Fecal Microbiota Transplant, Placebo; Biological
Lead sponsor: University of Vermont; Other
Eligibility: 18 Years to 75 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2018
U.S. locations: 1
States / cities: Burlington, Vermont

Conditions: Diabetic Foot Ulcer (DFU), Ulcer Foot, Diabetic Foot, Foot Ulcer
Interventions: Standard of Care, Revita, Relese, Cogenex, Enverse; Other
Lead sponsor: StimLabs; Industry
Eligibility: 18 Years and older
Enrollment: 272 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 5
States / cities: Omaha, Nebraska • Tulsa, Oklahoma • Jefferson Hills, Pennsylvania + 2 more

Conditions: Non-Healing Ulcer of Skin, Non-healing Wound, Lower Extremity Wound
Interventions: Microvessel Ultrasound Examination, Skin Biopsy; Diagnostic Test · Procedure
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Ulcerative Colitis
Interventions: AMT-101 (oral), Placebo (oral); Drug · Other
Lead sponsor: Applied Molecular Transport; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 105 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 15
States / cities: Rialto, California • Orlando, Florida • Port Orange, Florida + 12 more

Conditions: Ulcerative Colitis, Crohn's Disease
Interventions: Vedolizumab; Drug
Lead sponsor: Takeda; Industry
Eligibility: 2 Years to 17 Years
Enrollment: 89 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2020
U.S. locations: 27
States / cities: Los Angeles, California • Orange, California • San Francisco, California + 22 more

Search by objective public record fields.

Observational Study to Investigate the Use of Sterilized Porcine Placental Tissue in the Treatment of Chronic VLU

DFC 004 Biomarkers for Active Diabetic Foot Ulcers

Reactive vs. Proactive Pain Control in IBD

Dose Finding Study of HP802-247 in Venous Leg Ulcers

Diabetic Foot Ulcer Imaging- Study 2

Effect of an Oral Supplement Enriched in Amino Acids and the Leucine Metabolite B-hydroxy B-methylbutyrate (HMB)

Novel Home Care Device for High-Risk Diabetic Patients

Clinical Trial to Examine Effectiveness of a Human Allograft for Treatment of DFU and VLU

SDRM® vs. Collagen for Diabetic Foot Ulcers

A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Ulcerative Colitis (UC)

Safety and Pharmacokinetics Study of HE3286 in Patients With Active, Mild-to-Moderate Ulcerative Colitis

VE202 in Patients With Mild-to-Moderate Ulcerative Colitis

Autoimmune Paradoxical Reactions in IBD Longitudinal Cohort

Entyvio (Vedolizumab) Long Term Safety Study

Efficacy and Safety Study of Apremilast to Treat Active Ulcerative Colitis

Effect of Hyaluronic Acid ECM on Venous Ulcers

Acute Care for Elders (ACE) Program at OHSU Hospital

Prevention of Recurrent Clostridium Difficile Infection (CDI) in Patients With Inflammatory Bowel Disease (IBD).

Non-healing Venous Leg Ulcers Treated With Standard Care With or Without BR-AC

Fecal Microbiota Transplant in the Treatment of Ulcerative Colitis

Modified Platform Trial Assessing Multiple CAMPs and SOC vs SOC Alone in the Treatment of Hard-to-Heal DFUs

A Study to Evaluate Microvessel Ultrasound Imaging of Wound Healing in Patients With Chronic Ulcers

Study of the Efficacy and Safety of AMT-101 in Subjects With Ulcerative Colitis (LOMBARD)

Vedolizumab IV in Pediatric Participants With Ulcerative Colitis (UC) or Crohn's Disease (CD)